Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR8554 for postoperative pain after orthopedic surgery
CTR20220639Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegileridine in postoperative pain, sponsored by Hengrui Therapeutics. Started Mar 2022; status: completed.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20220639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220639.